Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 22:9:971622.
doi: 10.3389/fmed.2022.971622. eCollection 2022.

Lower insulin level is associated with sarcopenia in community-dwelling frail and non-frail older adults

Yanxia Lu  1 , Wee Shiong Lim  2   3 , Xia Jin  4 , Ma Schwe Zin Nyunt  5 , Tamas Fulop  6 , Qi Gao  5 , Su Chi Lim  7 , Anis Larbi  6   8 , Tze Pin Ng  5
Affiliations

Lower insulin level is associated with sarcopenia in community-dwelling frail and non-frail older adults

Yanxia Lu et al. Front Med (Lausanne). .

Abstract

Background: Sarcopenia is common among older individuals with and without type 2 diabetes mellitus (T2DM). There are conflicting evidence in support of the role of insulin in the development of age-related and T2DM-related sarcopenia. We investigated the relationships between the levels of fasting insulin and other blood biomarkers related to insulin or lipid metabolism with the presence of sarcopenia in two independent studies.

Materials and methods: In 246 pre-frail frail older individuals with (n = 41) and without T2DM (n = 205) in the Singapore Frailty Interventional Trial, sarcopenia was defined by low appendicular lean mass (ALM) relative to total body mass (skeletal muscle index, SMI = ALM/height2) and low lower limb strength or gait speed according to the Asian Working Group for Sarcopenia (AWGS) criteria released in 2019, and related to levels of fasting insulin and glucose, C-peptide, IGF-1, leptin, and active ghrelin. This investigation was validated in another independent study sample of 189 robust and pre-frail frail elderly in the Singapore Longitudinal Aging Study Wave 2 (SLAS-2).

Results: Compared to non-sarcopenic individuals, those with sarcopenia and possible sarcopenia showed significantly lower fasting insulin (p < 0.05) in pre-frail/frail and non-frail older individuals. Consistent trends of relationships were observed for serum levels of C-peptide, IGF-1, leptin, and active ghrelin. In multivariable logistic regression models, sarcopenia was independently associated with low insulin (p < 0.05). Levels of fasting insulin, C-peptide, and leptin were also significantly associated with BMI, SMI, knee extension strength, gait speed, and physical activity score.

Conclusion: Dysregulated insulin secretion in diabetic and non-diabetic older individuals may play an important role in age-related and diabetes-related sarcopenia.

Keywords: aging; diabetes; frailty; insulin; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Participant recruitment flowchart in the exploratory study.
FIGURE 2
FIGURE 2
Participant recruitment flowchart in the validation study.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diab Endocrinol. (2014) 2:819–29. 10.1016/s2213-858770034-8 - DOI - PMC - PubMed
    1. Drew L. Fighting the inevitability of ageing. Nature. (2018) 555:S15–7. 10.1038/d41586-018-02479-z - DOI - PubMed
    1. Wiedmer P, Jung T, Castro JP, Pomatto LCD, Sun PY, Davies KJA, et al. Sarcopenia – molecular mechanisms and open questions. Ageing Res Rev. (2021) 65:101200. 10.1016/j.arr.2020.101200 - DOI - PubMed
    1. Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho F, Pell JP, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. (2022) 13:86–99. 10.1002/jcsm.12783 - DOI - PMC - PubMed
    1. Sarcopenia E. A fate worth challenging. Lancet Diab Endocrinol. (2014) 2:183. 10.1016/s2213-858770055-5 - DOI - PubMed